These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
85 related items for PubMed ID: 8516899
1. Lidocaine metabolite formation in the liver donor as a predictive test for the safe and efficient introduction of cyclosporine in the recipient. Azoulay D, Lemoine A, Gries JM, Adam R, Dolizy I, Fredj G, Beaune P, Bismuth H. Transplant Proc; 1993 Jun; 25(3):2275-8. PubMed ID: 8516899 [No Abstract] [Full Text] [Related]
2. Histological comparison of donor livers and lidocaine metabolism in the utilization of organs for liver transplantation. Rosenlof LK, Sawyer RG, Broccoli AV, Ishitani MB, Stevenson WC, Pruett TL. Transplant Proc; 1993 Feb; 25(1 Pt 2):1662-3. PubMed ID: 8442229 [No Abstract] [Full Text] [Related]
3. Metabolic liver function and lipoprotein metabolism after orthotopic liver transplantation in patients on immunosuppressive therapy with FK 506 or cyclosporine. Armstrong VW, Kaltefleiter M, Luy-Kaltefleiter M, Schütz E, Wieland E, Loss M, Winkler M, Ringe B, Oellerich M. Transplant Proc; 1995 Feb; 27(1):1201-3. PubMed ID: 7533371 [No Abstract] [Full Text] [Related]
4. Acute cyclosporine toxicity after liver transplantation is predicted by the lidocaine monoethylglycinexylidide test in the donor. Azoulay D, Adam R, Pham P, Salvucci M, Davoll S, Bismuth H, Debuire B, Lemoine A. Liver Transpl Surg; 1997 Sep; 3(5):526-31. PubMed ID: 9346796 [Abstract] [Full Text] [Related]
5. Lidocaine metabolism as an index of liver function in hepatic transplant donors and recipients. Schroeder TJ, Gremse DA, Mansour ME, Theuerling AW, Brunson ME, Ryckman FC, Suchy FJ, Penn I, Alexander JW, Pesce AJ. Transplant Proc; 1989 Feb; 21(1 Pt 2):2299-301. PubMed ID: 2652744 [No Abstract] [Full Text] [Related]
6. The value of the donor MEGX test in predicting liver allograft recipient outcome. Potter JM, Balderson GA, Hickman PE, Henderson A, Wright M, Burrow B, Lynch SV, Ong TH, Strong RW. Transplantation; 1994 Aug 27; 58(4):524-6. PubMed ID: 8073525 [No Abstract] [Full Text] [Related]
7. Lignocaine metabolite formation as a measure of pre-transplant liver function. Oellerich M, Burdelski M, Ringe B, Lamesch P, Gubernatis G, Bunzendahl H, Pichlmayr R, Herrmann H. Lancet; 1989 Mar 25; 1(8639):640-2. PubMed ID: 2564460 [Abstract] [Full Text] [Related]
8. Donor rating in human liver transplantation: correlation of oxygen consumption after revascularization with MEGX formation in donors. Burdelski M, Oellerich M, Bornscheuer A, Luebbe N, Ringe B, Lamesch P, Raude E, Raith H, Scheruhn M, Gubernatis G. Transplant Proc; 1989 Feb 25; 21(1 Pt 2):2392-3. PubMed ID: 2652779 [No Abstract] [Full Text] [Related]
9. Limits of the MEGX test in the selection of liver grafts for transplantation. Adam R, Azoulay D, Astarcioglu I, Chiche L, Bao YM, Bonhomme L, Lemoine A, Fredj G, Bismuth H. Transplant Proc; 1993 Feb 25; 25(1 Pt 2):1653-4. PubMed ID: 8442225 [No Abstract] [Full Text] [Related]
10. MEGX as a test of donor liver function. Balderson GA, Potter JM, Hickman PE, Chen Y, Lynch SV, Strong RW. Transplant Proc; 1992 Oct 25; 24(5):1960-1. PubMed ID: 1412928 [No Abstract] [Full Text] [Related]
11. Relationship between cytochrome P-450 3A content of orthotopically transplanted liver and postoperative morbidity. Azoulay D, Lemoine A, Dennison A, Gries JM, Dolizy I, Barbazza F, Bonhomme L, Beaune P, Bismuth H. Transplant Proc; 1993 Aug 25; 25(4):2630-1. PubMed ID: 8356702 [No Abstract] [Full Text] [Related]
12. Donor hyaluronic acid and MEGX levels do not accurately predict posttransplant liver function. Michell ID, Abdulnour I, Pzybylowski G, Bowkett J, Gleeson A, Hardy KJ, Jones RM. Transplant Proc; 1993 Oct 25; 25(5):2888-9. PubMed ID: 8212275 [No Abstract] [Full Text] [Related]
13. Safe use of liver donors with MEGX values less than 90 ng/mL. Tesi RJ, Elkhammas EA, Davies EA, Salazar A, Henry ML, Greenson J, Ferguson RM. Transplant Proc; 1993 Feb 25; 25(1 Pt 2):1655-6. PubMed ID: 8442226 [No Abstract] [Full Text] [Related]
14. Lignocaine metabolism and MEGX production in the liver transplant donor. Potter JM, Hickman PE, Balderson G, Lynch SV, Strong R. Transplant Proc; 1992 Feb 25; 24(1):198-9. PubMed ID: 1539243 [No Abstract] [Full Text] [Related]
15. The yin and yang of lidocaine and cyclosporine metabolism in liver graft recipients. Christians U, Kohlhaw K, Esselmann H, Sürig T, Luy M, Kaltefleiter M, Beyrau R, Linck A, Ringe B, Oellerich M. Transplant Proc; 1994 Oct 25; 26(5):2827-8. PubMed ID: 7940891 [No Abstract] [Full Text] [Related]
16. Reliability of the MEGX test in the selection of liver grafts. Adam R, Azoulay D, Astarcioglu I, Bao YM, Bonhomme L, Fredj G, Bismuth H. Transplant Proc; 1991 Oct 25; 23(5):2470-1. PubMed ID: 1926438 [No Abstract] [Full Text] [Related]
17. [Dynamic liver function study using the lidocaine test]. Sídlová K, Průsa R. Cas Lek Cesk; 2000 Sep 27; 139(19):604-5. PubMed ID: 11192753 [Abstract] [Full Text] [Related]
18. Monoethylglycinexylidide clearance test: its role as a part of brain-dead donors' evaluation for liver transplantation. Bruzzone P, Alfani D, Rossi M, Berloco P, Cortesini R. Transplant Proc; 1993 Dec 27; 25(6):3112-3. PubMed ID: 8266476 [No Abstract] [Full Text] [Related]
19. Assessment of prognosis in transplant candidates by use of the Pugh-MEGX score. Oellerich M, Hartmann H, Ringe B, Burdelski M, Lautz HU, Pichlmayr R. Transplant Proc; 1993 Feb 27; 25(1 Pt 2):1116-9. PubMed ID: 8442062 [No Abstract] [Full Text] [Related]
20. The lidocaine monoethylglycinexylidide test of liver function. Ghent CN, Wall WJ. Liver Transpl Surg; 1996 May 27; 2(3):242-5. PubMed ID: 9346657 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]